TrianglePUBLICATIONS · 24449310
The accelerated approval of oncologic drugs: lessons from ponatinib.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- JAMA
- Publication date
- 2014 Jan 22-29
- First author
- Prasad V
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Prasad V
- type
- Author
- name
- Mailankody S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Prasad V
- type
- Author
- name
- Mailankody S
- type
- Author
- bibliography ids
- nci-bib-ed9932399171d2edf81b1dae
- book metadata
- content sha256
- 886e41f049fcd4ff96d5fdcb5e208217b6cc3c0a51f5882c47accd7dc14b94f1
- document type
- citation
- dois
- 10.1001/jama.2013.284531
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24449310
- immutable id
- pubmed:24449310@886e41f049fcd4ff96d5fdcb5e208217b6cc3c0a51f5882c47accd7dc14b94f1
- journal
- abbreviation
- JAMA
- issn electronic
- 1538-3598
- issn print
- 0098-7484
- issue
- 4
- name
- JAMA
- nlm unique id
- 7501160
- pages
- 353-4
- volume
- 311
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24449310
- provenance
- batch id
- af10498814d931b53231
- provider
- NCBI PubMed ESummary
- record sha256
- 9efe1f8c075cbc908d96ecbff56a49db4b0378b4b854c07fb12def8634a768ba
- response sha256
- 077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
- retrieved at
- 2026-09-09T23:47:00.193465+00:00
- publication date
- display
- 2014 Jan 22-29
- precision
- range_or_season
- year
- 2014
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- The accelerated approval of oncologic drugs: lessons from ponatinib.
Preserved source evidence · Not medical advice